The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...

Recent advancements include targeted agents, immunotherapy, and fertility-sparing surgeries for patients with advanced ...

During Cervical Cancer Awareness Month, Dr. Merieme Klobocista, a gynecologic surgical oncologist affiliated with Hackensack University Medical Center and the John Theurer Cancer Center at Hackensack ...

While exemptions on key imported cancer therapies promise reduced treatment costs for patients, oncologists say preventing ...

SCAC, while rare, is primarily driven by the human papillomavirus (HPV) and accounts for about 85% of all anal cancers. There ...

New options for testing and treating some of the most common sexually transmitted diseases are becoming available, a trend ...

New cancer therapies are dramatically improving outcomes while personalized medicine approaches emerge.

Maria Aileen Pascual, a breast cancer warrior, continues to share her story, hoping to inspire others to face cancer with courage rather than fear. Pascual was diagnosed with Stage 1 breast cancer in ...

HARLINGEN, Texas (ValleyCentral) — January is Cervical Cancer Awareness Month, and Valley doctors say prevention is key. Cervical cancer originates from the human papillomavirus or HPV, and poses a ...

Standardised screening guidelines are crucial for meeting the World Health Organisation 2030 targets aimed at accelerating the elimination of cervical cancer ...

Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® HPV Assay received FDA approval for clinician-collected HPV primary screening. Hologic’s human papillomavirus (HPV) test is the only ...

February is National Cancer Prevention Month, a time dedicated to educating people on how they can reduce their risk of ...